PRAXIS PRECISION MEDICINES, INC. Accumulated Other Comprehensive Income
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Accumulated Other Comprehensive Income of -$2.67 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.67M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.59M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $563.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $500.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$2.67M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$1.59M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $563.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $395.00K 10-Q · filed 2025-08-04 |
| 2025-03-31 | $659.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $654.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.33M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$71.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$19.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$173.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$536.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$680.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$606.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$176.00K 10-K · filed 2023-02-07 |
| 2021-09-30 | -$25.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | -$50.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$86.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |